GlassScriptPhysician profile
Sanjiv Sahoo
NPI 1679594899
$11,610.78
in general payments reported to CMS, 2019-2025
65 companies · $1,956 in 2025
The $1,956 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $1,350 · 2021: $1,493 · 2022: $1,754 · 2023: $2,197 · 2024: $1,396 · 2025: $1,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,500 · Education: $48.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,500.27 |
| Education | $48.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,511.59 | 2021-2025 | Botox, Duopa, Qulipta |
| Ucb, INC. | $894.17 | 2019-2025 | Fintepla, Briviact, Rystiggo |
| Sunovion Pharmaceuticals INC. | $506.96 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $479.91 | 2021-2025 | Hyqvia, Gammagard |
| Novartis Pharmaceuticals Corporation | $381.72 | 2019-2025 | |
| Biogen, INC. | $369.85 | 2019-2023 | Vumerity, Tysabri |
| Lundbeck LLC | $343.13 | 2020-2025 | Vyepti |
| Allergan, INC. | $293.85 | 2019-2022 | |
| Csl Behring | $288.98 | 2019-2024 | Hizentra, Kcentra |
| Jazz Pharmaceuticals INC. | $286.39 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $285.93 | 2021-2025 | Wainua, Andexxa |
| Lilly USA, LLC | $269.40 | 2019-2025 | Jardiance, Kisunla, Emgality |
| Sk Life Science, INC. | $249.09 | 2020-2025 | |
| Amgen INC. | $240.48 | 2019-2025 | Uplizna |
| Supernus Pharmaceuticals, INC. | $238.66 | 2019-2020 |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjiv Sahoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.